Showing results (1-10 of 5) with videos related to
Sort By:
Pageof 1
Vascular Health and Risk Management|May 14, 2009
Use of clopidogrel in the reduction of myocardial damage during percutaneous coronary interventionArijit Dasgupta, Debabrata MukherjeeDalton Transactions (Cambridge, England : 2003)|June 15, 2013
Synthesis and properties of a novel quarternerized imidazolium [α-PW12O40]3- salt as a recoverable photo-polymerization catalystDianyu Chen, Atharva Sahasrabudhe, Peng Wang, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|May 3, 2007
Increased complication rates of cardiac rhythm management devices in ESRD patientsArijit Dasgupta, Jessica Montalvo, Sara Medendorp, et al.American Heart Journal|March 29, 2008
The efficacy and safety of short- and long-term dual antiplatelet therapy in patients with mild or moderate chronic kidney disease: results from the Clopidogrel for the Reduction of Events During Observation (CREDO) trialPatricia J M Best, Steven R Steinhubl, Peter B Berger, et al.The American Journal of Cardiology|May 12, 2009
Clinical outcomes of patients with diabetic nephropathy randomized to clopidogrel plus aspirin versus aspirin alone (a post hoc analysis of the clopidogrel for high atherothrombotic risk and ischemic stabilization, management, and avoidance [CHARISMA] trial)Arijit Dasgupta, Steven R Steinhubl, Deepak L Bhatt, et al.Pageof 1